Consistent functional brain abnormalities in Parkinson's disease (PD) are difficult to pinpoint because differences from the normal state are often subtle. In this regard, the application of multivariate methods of analysis has been successful but not devoid of misinterpretation and controversy. The Scaled Subprofile Model (SSM), a principal components analysis (PCA)-based spatial covariance method, has yielded critical information regarding the characteristic abnormalities of functional brain organization that underlie PD and other neurodegenerative disorders. However, the relevance of disease-related spatial covariance patterns (metabolic brain networks) and the most effective methods for their derivation has been a subject of debate. We address these issues here and discuss the inherent advantages of proper application as well as the effects of the misapplication of this methodology. We show that ratio pre-normalization using the mean global metabolic rate (GMR) or regional values from a "reference" brain region (e.g. cerebellum) that may be required in univariate analytical approaches is obviated in SSM. We discuss deviations of the methodology that may yield erroneous or confounding factors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020239PMC
http://dx.doi.org/10.1016/j.neuroimage.2010.10.025DOI Listing

Publication Analysis

Top Keywords

scaled subprofile
8
parkinson's disease
8
functional brain
8
spatial covariance
8
subprofile modeling
4
modeling resting
4
resting state
4
state imaging
4
imaging data
4
data parkinson's
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Baden-Wuerttemberg, Germany.

Background: Florzolotau (APN-1607) tau-PET has shown distinct patterns of binding in patients with AD and 4-repeat tauopathies. We aimed to establish disease-specific tau covariance patterns in AD and PSP/CBS and validate them as user-independent quantitative biomarkers for reference-region-free evaluation of tau-PET in an independent clinical cohort.

Method: We analyzed Florzolotau PET data from four different cohorts.

View Article and Find Full Text PDF

Alzheimer's Imaging Consortium.

Alzheimers Dement

December 2024

Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Baden-Wuerttemberg, Germany.

Background: Florzolotau (APN-1607) tau-PET has shown distinct patterns of binding in patients with AD and 4-repeat tauopathies. We aimed to establish disease-specific tau covariance patterns in AD and PSP/CBS and validate them as user-independent quantitative biomarkers for reference-region-free evaluation of tau-PET in an independent clinical cohort.

Method: We analyzed Florzolotau PET data from four different cohorts.

View Article and Find Full Text PDF

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder and its underlying neuroanatomical mechanisms still remain unclear. The scaled subprofile model of principal component analysis (SSM-PCA) is a data-driven multivariate technique for capturing stable disease-related spatial covariance pattern. Here, SSM-PCA is innovatively applied to obtain robust ASD-related gray matter volume pattern associated with clinical symptoms.

View Article and Find Full Text PDF
Article Synopsis
  • Multiple sclerosis (MS) has two primary types: relapse-remitting MS (RRMS) and progressive MS (PMS), which differ in disability and treatment response, making it hard to identify using traditional MRI.
  • A study utilized scaled subprofile modeling with principal component analysis (SSM/PCA) on MRI scans from RRMS and PMS patients to better distinguish these MS types.
  • Results showed that qihMT imagery provided the best differentiation between PMS and RRMS at 87% specificity, while Tw data offered higher sensitivity at 93%; when both analyses agreed, prediction accuracy increased significantly for identifying MS phenotypes.
View Article and Find Full Text PDF

Homocysteine (Hcy) is a cardiovascular risk factor implicated in cognitive impairment and cerebrovascular disease but has also been associated with Alzheimer's disease. In 160 healthy older adults (mean age = 69.66 ± 9.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!